476060.KQ
Onconic Therapeutics
KOE · Healthcare · Biotechnology · KR
KRW 17,110.00
+1.85%Leverage
- Debt / equity
- 0.00x
- Net debt / equity
- -0.67x
- Debt / assets
- 0.00x
- Debt / EBITDA
- 0.01x
- Net debt / EBITDA
- -3.05x
Liquidity & coverage
- Current ratio
- 11.39x
- Quick ratio
- 11.39x
- Cash ratio
- 8.81x
- Interest coverage
- —
- EBITDA / interest
- —
- Working capital
- KRW 73.9B
Cash & dividend
- FCF / debt
- 60.89x
- Cash flow / debt
- 62.06x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Jun 1, 2026